Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04940429 · ClinicalTrials.gov registry record
Eye Movement Testing in Patients With Obesity and the Impact of Weight Loss Surgery
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 19
- Enrollment target
NCT04940429: Clinical Trial study, sponsored by Stanford University.
NCT04940429 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04940429 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
Obesity is a condition of chronic low-grade inflammation, thought to be secondary to adipose tissue secretion of cytokines including interleukin 6 (IL-6), and tumor necrosis factor alpha (TNF- α) which effect multiple pathways and lead to an increase in C-reactive protein (CRP), a sensitive marker of systemic inflammation. Chronic inflammation is thought to be a major risk factor for the development of metabolic syndrome, diabetes, cardiovascular disease and cancer. Inflammatory cytokines have also been shown to directly and indirectly interact with the central nervous system influencing behavior and neural activity. Obesity is an independent risk factor for reduced cognitive function including poor attention, executive function and memory. Demonstrating improvement in dynamic visual processing following bariatric surgery could expand our understanding of the impact of obesity on central nervous system (CNS) function.
Interventions
- DEVICE Neurofit
- DIAGNOSTIC_TEST Psychometric hepatic encephalopathy score
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-11-27 |
| Est. Completion | 2021-06-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04940429
The ClinicalTrials.gov registry entry for NCT04940429 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Neurofit is the first listed.
NCT04940429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04940429 about?
NCT04940429 is a clinical study titled "Eye Movement Testing in Patients With Obesity and the Impact of Weight Loss Surgery". Obesity is a condition of chronic low-grade inflammation, thought to be secondary to adipose tissue secretion of cytokines including interleukin 6 (IL-6), and tumor necrosis factor alpha (TNF- α) which effect multiple pathways and lead to an increase in C-reactive protein (CRP), a sensitive marker o...
What is the current status of trial NCT04940429?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2018-11-27. Estimated completion is 2021-06-17.
What interventions are being tested in trial NCT04940429?
The interventions under investigation include: Neurofit (DEVICE), Psychometric hepatic encephalopathy score (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04940429?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.